GL1X · GenesisL1 explorer

Research workbench

Crystal structure of pantothenate synthetase from M. tuberculosis in complex with a reaction intermediate, pantoyl adenylate, different occupancies of pantoyl adenylate

Analyse Crystal structure of pantothenate synthetase from M. tuberculosis in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1N2I
Type
protein
Length
573 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pantothenate synthetase
EC
6.3.2.1
UniProt
P0A5R0
Ligands
PAJ, SO4
Pockets
5 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APantothenate synthetase (EC 6.3.2.1)protein28643% helix, 22% strandP0A5R0
BPantothenate synthetase (EC 6.3.2.1)protein28742% helix, 23% strandP0A5R0

Ligands and binding sites

  • PAJ · Pantoyl adenylate · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A, B
  • EOH · Ethanol · additive · 5 copies · chains B, A
  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15610.830.8859SO4, PAJ
25970.810.8757PAJ
33330.620.7933empty
4680.350.7618empty
5710.320.7515empty

Interfaces

1 interface between chains.

  • A–B · 1210 Ų buried · 25 hydrogen bonds · protein-protein

Compared structures

  • 1N2I · Crystal Structure of Pantothenate Synthetase from M. tuberculosis in complex with a… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.